BioSpace News Archive

Business

Aquestive Therapeutics to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 2 and Host Conference Call on May 3 at 8:00 a.m. ET

Aquestive Therapeutics, Inc. today announced that it will report results for first quarter ended March 31, 2023, and provide an update on recent developments in its business after market close on Tuesday, May 2, 2023.

April 18, 2023

·

3 min read

Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock Patients

Spectral Medical Inc. today announced positive results in EUPHAS-2.

April 18, 2023

·

5 min read

Drug Development

Assembly Biosciences Announces Additional Promising Data from Phase 1a Clinical Trial Evaluating Highly Potent Next-Generation Core Inhibitor Candidate ABI-4334 and Provides Pipeline Update

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today provided an update of results from the final multiple-dose cohort in the ongoing Phase 1a study of its investigational next-generation, highly potent hepatitis B virus (HBV) core inhibitor, ABI-4334.

April 18, 2023

·

7 min read

Biotech Bay

ProSomnus® Announces Publication of Four Accepted Abstracts in the Journal of Dental Sleep Medicine in Advance of Annual Meeting

ProSomnus, Inc. today announced the publication of four abstracts in the Journal of Dental Sleep Medicine.

April 18, 2023

·

2 min read

Femasys’ FemaSeed Localized Directional Insemination for Infertility Receives Product Approval in Canada

Femasys Inc. (NASDAQ: FEMY) today announced the Health Canada, the Public Health Agency of Canada, has granted product approval of FemaSeed®, the first-ever infertility solution designed to deliver sperm directly to where contraception occurs.

April 18, 2023

·

4 min read

BioMidwest

HTG Announces Key 2023 First Quarter Milestone Achievements for Drug Discovery

HTG Molecular Diagnostics, Inc., a platform-based life science tools and drug discovery company, announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.

April 18, 2023

·

5 min read

Pharm Country

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023

ProPhase Labs, Inc. today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 at 10:30 am PST, 1:30 pm EST.

April 18, 2023

·

4 min read

Biotech Beach

Arcutis Announces FDA Acceptance of New Drug Application for Roflumilast Foam 0.3% for the Treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older

Arcutis Biotherapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for review the company’s new drug application (NDA) for roflumilast foam 0.3% for the treatment of seborrheic dermatitis in individuals 9 years of age and older.

April 18, 2023

·

7 min read

BioForest

Cocrystal Pharma to Present New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference

Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the acceptance of an oral presentation containing new data from the Company’s CC-42344 Phase 1 influenza A study at the 7th Annual International Society for Influenza and Other Respiratory Virus Diseases’ (ISIRV) Antiviral Group Conference.

April 18, 2023

·

4 min read

Business

Sotera Health Announces First-Quarter 2023 Earnings Release Date

Sotera Health Company announced its plans to release its financial results for the first-quarter ended March 31, 2023 before the market opens on Wednesday, May 3, 2023.

April 18, 2023

·

1 min read